The Adeno Associated Virus Vector Manufacturing Market is poised for robust growth, with a projected compound annual growth rate (CAGR) of approximately 12.8% expected to propel the market to reach USD 3.21 billion by 2030. This growth is driven by increasing demand for gene therapy treatments and advancements in biotechnology and genetic engineering. Key players in the...